The Food and Drug Administration recently approved the FreeStyle Libre Pro system, a continuous glucose monitoring system developed by Abbott Park, Ill.-based Abbott.
To use the system, clinicians attach a small, disposable sensor on the back of a patient's arm. The sensor, worn for two weeks, continuously measures glucose and records levels every 15 minutes. At the end of the fourteen days, the patient attends a follow-up appointment where the physician uses a FreeStyle Libre Pro reader to scan the sensor and download the patient's glucose results stored in the sensor.
"This technology is groundbreaking because continuous glucose monitoring systems for professional use have been long considered a niche, cumbersome, and expensive technology for mostly Type 1 patients," said Eugene Wright, Jr., MD, physician at Duke Southern Regional Area Health Education Center in Fayetteville, N.C. "The FreeStyle Libre Pro system changes this paradigm not only because of the unique technology but because it doesn't require fingerstick calibration, is easier to use, more affordable, and is more accessible to people with diabetes."
More articles on supply chain:
Why patient advocacy groups are silent about high drug prices
Amazon wants to scale up distribution network to compete with FedEx, UPS
5 things to know about the international X-ray gap